BCL2 and neoplasm: These data indicate that bcl-xL is a potent anti-apoptotic gene and tumor progression factor when up-regulated/over-expressed during lymphoid and pancreatic islet tumorigenesis, but that its anti-apoptotic functions are in some circumstances non-essential, likely due to the redundant functions of the other expressed Bcl-2 family members.